MongoDB stock drops about 4% in late trade as software sector slides — what’s next for MDB

MongoDB stock drops about 4% in late trade as software sector slides — what’s next for MDB

New York, January 2, 2026, 15:34 ET — Regular session

  • MongoDB fell with other software names even as the broader market held steady.
  • Wall Street opened 2026 cautious on valuations and the rate outlook.
  • Next week’s U.S. jobs report and inflation data are key tests for growth-stock sentiment.

MongoDB, Inc. shares slid about 4% in afternoon trading on Friday, falling to around $402 and underperforming the broader market as software stocks weakened on the first trading day of 2026.

The move matters because MongoDB trades like a classic “risk-on” software stock — the kind that can swing hard when investors reassess valuations and interest-rate expectations. “Stocks trade expensive on 18 of 20 measures,” Bank of America equity and quant strategist Savita Subramanian wrote in a note. 1

Software was a notable drag: the iShares Expanded Tech-Software Sector ETF fell about 2.6%, while the SPDR S&P 500 ETF was up roughly 0.2% and the Invesco QQQ was little changed. Snowflake, Datadog and Elastic were also lower in afternoon trading.

MongoDB sells database software used to store and manage application data, and it competes in a crowded market for enterprise data infrastructure. 2

The stock swung sharply on the day, rising early before reversing lower and testing a round-number support level near $400 as sellers took control.

Next week’s U.S. economic calendar could set the tone for growth stocks, with the monthly jobs report due January 9 and the consumer price index report due January 13, Reuters reported. 3

For software shares, those releases matter because interest-rate expectations feed directly into how investors value future earnings — the faster the expected growth, the more sensitive the stock often is to shifts in rates.

Investors are also looking ahead to MongoDB’s next earnings update. MarketBeat’s earnings calendar estimates the next report for March 4, based on the company’s past reporting schedule. 4

On the company calendar, MongoDB is slated to hold a MongoDB.local event in San Francisco on January 15 that it says will include product announcements and a keynote — an item some investors may watch for new signals on product direction. 5

Stock Market Today

Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
SSE share price near 2,510p as BoE rate-cut bets return; UK GDP and SSE updates ahead

SSE share price near 2,510p as BoE rate-cut bets return; UK GDP and SSE updates ahead

7 February 2026
SSE shares closed Friday at 2,510p, up 1.2%, with about 6.6 million shares traded. The company’s transmission arm secured over £6.9 million in Ofgem innovation funding for four projects. Investors adjusted UK rate-cut bets after a split Bank of England decision. SSE maintained 2025/26 earnings guidance and reported a 7% rise in renewables output.
Kymera Therapeutics stock slides nearly 7% after CEO share-sale filing — what KYMR investors watch next
Previous Story

Kymera Therapeutics stock slides nearly 7% after CEO share-sale filing — what KYMR investors watch next

Synopsys stock rises nearly 3% today as Loop Capital lifts target to $600; SNPS outperforms peers
Next Story

Synopsys stock rises nearly 3% today as Loop Capital lifts target to $600; SNPS outperforms peers

Go toTop